Improving personalized treatment for depression using cognitive assessments
ACE-D: Accelerating Cognition-guided signatures to Enhance translation in Depression
This study is creating a friendly app that helps people with depression by tracking their behavior to better understand their needs and improve their treatment options.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11083724 on NIH RePORTER |
What this research studies
This research aims to develop a personalized cognitive assessment tool for individuals with depression, addressing the need for better clinical decision-making. By utilizing behavioral measures based on neural mechanisms, the project will create a clinical cognitive signature that can predict treatment outcomes for patients. Participants will engage with a smartphone application that collects behavioral data, allowing for real-time monitoring and tailored treatment options. The study will analyze data from a diverse group of participants, including those with major depressive disorder, to refine these assessments.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who are experiencing major depressive disorder and are seeking personalized treatment options.
Not a fit: Patients with depression who are not willing or able to engage with smartphone technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for individuals suffering from depression.
How similar studies have performed: Previous research has shown promise in using cognitive assessments and technology for improving treatment outcomes in depression, indicating that this approach could be effective.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Williams, Leanne — Stanford University
- Study coordinator: Williams, Leanne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.